位置:首页 > 蛋白库 > UNC5B_RAT
UNC5B_RAT
ID   UNC5B_RAT               Reviewed;         945 AA.
AC   O08722;
DT   11-OCT-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   25-MAY-2022, entry version 145.
DE   RecName: Full=Netrin receptor UNC5B;
DE   AltName: Full=Protein unc-5 homolog 2;
DE   AltName: Full=Protein unc-5 homolog B;
DE   Flags: Precursor;
GN   Name=Unc5b; Synonyms=Unc5h2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=9126742; DOI=10.1038/386833a0;
RA   Leonardo E.D., Hinck L., Masu M., Keino-Masu K., Ackerman S.L.,
RA   Tessier-Lavigne M.;
RT   "Vertebrate homologues of C. elegans UNC-5 are candidate netrin
RT   receptors.";
RL   Nature 386:833-838(1997).
RN   [2]
RP   FUNCTION, AND INTERACTION WITH DCC.
RX   PubMed=10399920; DOI=10.1016/s0092-8674(00)80804-1;
RA   Hong K., Hinck L., Nishiyama M., Poo M.-M., Tessier-Lavigne M., Stein E.;
RT   "A ligand-gated association between cytoplasmic domains of UNC5 and DCC
RT   family receptors converts netrin-induced growth cone attraction to
RT   repulsion.";
RL   Cell 97:927-941(1999).
RN   [3]
RP   FUNCTION, MUTAGENESIS OF ASP-412, AND PROTEOLYTIC CLEAVAGE.
RX   PubMed=11387206; DOI=10.1093/emboj/20.11.2715;
RA   Llambi F., Causeret F., Bloch-Gallego E., Mehlen P.;
RT   "Netrin-1 acts as a survival factor via its receptors UNC5H and DCC.";
RL   EMBO J. 20:2715-2722(2001).
RN   [4]
RP   FUNCTION, AND INTERACTION WITH DAPK1.
RX   PubMed=15729359; DOI=10.1038/sj.emboj.7600584;
RA   Llambi F., Lourenco F.C., Gozuacik D., Guix C., Pays L., Del Rio G.,
RA   Kimchi A., Mehlen P.;
RT   "The dependence receptor UNC5H2 mediates apoptosis through DAP-kinase.";
RL   EMBO J. 24:1192-1201(2005).
RN   [5]
RP   FUNCTION, PALMITOYLATION AT CYS-403, SUBCELLULAR LOCATION, AND INTERACTION
RP   WITH DAPK1.
RX   PubMed=18582460; DOI=10.1016/j.yexcr.2008.06.001;
RA   Maisse C., Rossin A., Cahuzac N., Paradisi A., Klein C., Haillot M.L.,
RA   Herincs Z., Mehlen P., Hueber A.O.;
RT   "Lipid raft localization and palmitoylation: identification of two
RT   requirements for cell death induction by the tumor suppressors UNC5H.";
RL   Exp. Cell Res. 314:2544-2552(2008).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 543-945, DOMAIN ZU5, AND DOMAIN
RP   UPA.
RX   PubMed=19328064; DOI=10.1016/j.molcel.2009.02.016;
RA   Wang R., Wei Z., Jin H., Wu H., Yu C., Wen W., Chan L.N., Wen Z., Zhang M.;
RT   "Autoinhibition of UNC5b revealed by the cytoplasmic domain structure of
RT   the receptor.";
RL   Mol. Cell 33:692-703(2009).
CC   -!- FUNCTION: Receptor for netrin required for axon guidance. Mediates axon
CC       repulsion of neuronal growth cones in the developing nervous system
CC       upon ligand binding. Axon repulsion in growth cones may be caused by
CC       its association with DCC that may trigger signaling for repulsion
CC       (PubMed:10399920, PubMed:9126742). Functions as netrin receptor that
CC       negatively regulates vascular branching during angiogenesis. Mediates
CC       retraction of tip cell filopodia on endothelial growth cones in
CC       response to netrin (By similarity). It also acts as a dependence
CC       receptor required for apoptosis induction when not associated with
CC       netrin ligand (PubMed:11387206). Mediates apoptosis by activating DAPK1
CC       (PubMed:18582460). In the absence of NTN1, activates DAPK1 by reducing
CC       its autoinhibitory phosphorylation at Ser-308 thereby increasing its
CC       catalytic activity (PubMed:15729359). {ECO:0000250|UniProtKB:Q8K1S3,
CC       ECO:0000269|PubMed:10399920, ECO:0000269|PubMed:11387206,
CC       ECO:0000269|PubMed:15729359, ECO:0000269|PubMed:18582460,
CC       ECO:0000305|PubMed:9126742}.
CC   -!- SUBUNIT: Interacts with the cytoplasmic part of DCC (PubMed:10399920).
CC       Interacts with GNAI2 via its cytoplasmic part (By similarity).
CC       Interacts (via death domain) with DAPK1 (via death domain)
CC       (PubMed:15729359, PubMed:18582460). Interacts (via extracellular
CC       domain) with FLRT3 (via extracellular domain); the interaction is
CC       direct. Interacts (via extracellular domain) with FLRT2 and FLRT3 (via
CC       extracellular domain), but has higher affinity for FLRT3. Identified in
CC       a complex with FLRT3 and ADGRL3; does not interact with ADGRL3 by
CC       itself (By similarity). {ECO:0000250|UniProtKB:Q8IZJ1,
CC       ECO:0000269|PubMed:10399920, ECO:0000269|PubMed:15729359,
CC       ECO:0000269|PubMed:18582460}.
CC   -!- INTERACTION:
CC       O08722; Q8CGU4: Agap2; NbExp=6; IntAct=EBI-4404185, EBI-4409108;
CC       O08722; P30154: PPP2R1B; Xeno; NbExp=4; IntAct=EBI-4404185, EBI-357094;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:9126742};
CC       Single-pass type I membrane protein {ECO:0000269|PubMed:9126742}.
CC       Membrane raft {ECO:0000269|PubMed:18582460}. Note=Associated with lipid
CC       rafts (PubMed:18582460). {ECO:0000269|PubMed:18582460}.
CC   -!- TISSUE SPECIFICITY: Mainly expressed in regions of differentiating
CC       neurons. Expressed in the developing sensory ganglia that flank the
CC       spinal cord from E12, peaking at E14. Expressed in the roof plate
CC       region of the spinal cord from E14. {ECO:0000269|PubMed:9126742}.
CC   -!- PTM: Phosphorylated on cytoplasmic tyrosine residues. {ECO:0000250}.
CC   -!- PTM: Proteolytically cleaved by caspases during apoptosis. The cleavage
CC       does not take place when the receptor is associated with netrin ligand.
CC       Its cleavage by caspases is required to induce apoptosis.
CC       {ECO:0000269|PubMed:11387206}.
CC   -!- PTM: Palmitoylation is required for pro-apoptotic activity, but not for
CC       location at lipid rafts. {ECO:0000269|PubMed:18582460}.
CC   -!- SIMILARITY: Belongs to the unc-5 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U87306; AAB57679.1; -; mRNA.
DR   RefSeq; NP_071543.1; NM_022207.1.
DR   PDB; 3G5B; X-ray; 2.00 A; A=541-945.
DR   PDBsum; 3G5B; -.
DR   AlphaFoldDB; O08722; -.
DR   SMR; O08722; -.
DR   DIP; DIP-60743N; -.
DR   IntAct; O08722; 5.
DR   STRING; 10116.ENSRNOP00000034951; -.
DR   GlyGen; O08722; 2 sites.
DR   iPTMnet; O08722; -.
DR   PhosphoSitePlus; O08722; -.
DR   jPOST; O08722; -.
DR   PaxDb; O08722; -.
DR   PRIDE; O08722; -.
DR   GeneID; 60630; -.
DR   KEGG; rno:60630; -.
DR   UCSC; RGD:621756; rat.
DR   CTD; 219699; -.
DR   RGD; 621756; Unc5b.
DR   eggNOG; KOG1480; Eukaryota.
DR   InParanoid; O08722; -.
DR   OrthoDB; 334938at2759; -.
DR   PhylomeDB; O08722; -.
DR   EvolutionaryTrace; O08722; -.
DR   PRO; PR:O08722; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0045121; C:membrane raft; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005042; F:netrin receptor activity; IDA:RGD.
DR   GO; GO:0033564; P:anterior/posterior axon guidance; ISO:RGD.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0007411; P:axon guidance; IDA:RGD.
DR   GO; GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; ISO:RGD.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISO:RGD.
DR   GO; GO:2001241; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; IMP:UniProtKB.
DR   GO; GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; ISO:RGD.
DR   CDD; cd08802; Death_UNC5B; 1.
DR   Gene3D; 1.10.533.10; -; 1.
DR   Gene3D; 2.20.100.10; -; 2.
DR   Gene3D; 2.60.40.10; -; 2.
DR   InterPro; IPR011029; DEATH-like_dom_sf.
DR   InterPro; IPR000488; Death_domain.
DR   InterPro; IPR042156; Death_UNC5B.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR000884; TSP1_rpt.
DR   InterPro; IPR036383; TSP1_rpt_sf.
DR   InterPro; IPR037936; UNC5.
DR   InterPro; IPR033772; UPA.
DR   InterPro; IPR000906; ZU5_dom.
DR   PANTHER; PTHR12582; PTHR12582; 1.
DR   Pfam; PF00531; Death; 1.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF00090; TSP_1; 2.
DR   Pfam; PF17217; UPA; 1.
DR   Pfam; PF00791; ZU5; 1.
DR   SMART; SM00005; DEATH; 1.
DR   SMART; SM00409; IG; 2.
DR   SMART; SM00408; IGc2; 1.
DR   SMART; SM00209; TSP1; 2.
DR   SMART; SM00218; ZU5; 1.
DR   SUPFAM; SSF47986; SSF47986; 1.
DR   SUPFAM; SSF48726; SSF48726; 2.
DR   SUPFAM; SSF82895; SSF82895; 2.
DR   PROSITE; PS50017; DEATH_DOMAIN; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS50092; TSP1; 2.
DR   PROSITE; PS51145; ZU5; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Apoptosis; Cell membrane; Developmental protein;
KW   Disulfide bond; Glycoprotein; Immunoglobulin domain; Lipoprotein; Membrane;
KW   Palmitate; Phosphoprotein; Receptor; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000255"
FT   CHAIN           27..945
FT                   /note="Netrin receptor UNC5B"
FT                   /id="PRO_0000036073"
FT   TOPO_DOM        27..377
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        378..398
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        399..945
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          48..145
FT                   /note="Ig-like"
FT   DOMAIN          153..242
FT                   /note="Ig-like C2-type"
FT   DOMAIN          246..300
FT                   /note="TSP type-1 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DOMAIN          302..354
FT                   /note="TSP type-1 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DOMAIN          543..686
FT                   /note="ZU5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00485"
FT   DOMAIN          865..943
FT                   /note="Death"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00064"
FT   REGION          689..838
FT                   /note="UPA domain"
FT   REGION          707..725
FT                   /note="Interaction with DCC"
FT                   /evidence="ECO:0000269|PubMed:10399920"
FT   SITE            412..413
FT                   /note="Cleavage; by caspase-3"
FT                   /evidence="ECO:0000305|PubMed:11387206"
FT   MOD_RES         581
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:O08747"
FT   LIPID           403
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000269|PubMed:18582460"
FT   CARBOHYD        222
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        347
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        69..130
FT                   /evidence="ECO:0000250|UniProtKB:Q6ZN44"
FT   DISULFID        81..128
FT                   /evidence="ECO:0000250|UniProtKB:Q6ZN44"
FT   DISULFID        174..225
FT                   /evidence="ECO:0000250|UniProtKB:Q6ZN44"
FT   DISULFID        258..295
FT                   /evidence="ECO:0000250"
FT   DISULFID        262..299
FT                   /evidence="ECO:0000250"
FT   DISULFID        273..285
FT                   /evidence="ECO:0000250"
FT   DISULFID        314..348
FT                   /evidence="ECO:0000250|UniProtKB:Q6ZN44"
FT   DISULFID        318..353
FT                   /evidence="ECO:0000250|UniProtKB:Q6ZN44"
FT   DISULFID        326..338
FT                   /evidence="ECO:0000250|UniProtKB:Q6ZN44"
FT   MUTAGEN         403
FT                   /note="C->V: Abolishes palmitoylation. Impairs interaction
FT                   with DAPK1. No effect on location on lipid rafts."
FT                   /evidence="ECO:0000269|PubMed:18582460"
FT   MUTAGEN         412
FT                   /note="D->N: Abolishes cleavage by caspase-3 and subsequent
FT                   induction of apoptosis."
FT                   /evidence="ECO:0000269|PubMed:11387206"
FT   STRAND          544..549
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   STRAND          554..558
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   TURN            559..562
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   STRAND          563..567
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   STRAND          578..584
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   HELIX           587..593
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   STRAND          598..600
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   STRAND          605..608
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   STRAND          618..623
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   STRAND          629..631
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   STRAND          634..642
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   STRAND          646..651
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   STRAND          660..665
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   STRAND          667..676
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   STRAND          678..685
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   STRAND          692..703
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   STRAND          707..720
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   HELIX           721..734
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   STRAND          736..738
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   STRAND          743..751
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   STRAND          754..759
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   TURN            763..765
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   STRAND          766..768
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   STRAND          771..773
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   STRAND          775..777
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   HELIX           779..783
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   STRAND          791..800
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   STRAND          805..814
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   STRAND          819..827
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   STRAND          849..851
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   TURN            852..855
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   HELIX           860..870
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   HELIX           880..886
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   TURN            891..893
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   HELIX           894..897
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   HELIX           902..914
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   HELIX           920..929
FT                   /evidence="ECO:0007829|PDB:3G5B"
FT   HELIX           934..940
FT                   /evidence="ECO:0007829|PDB:3G5B"
SQ   SEQUENCE   945 AA;  103521 MW;  6E9C2A262E560B9B CRC64;
     MRARSGARGA LLLALLLCWD PTPSLAGIDS GGQALPDSFP SAPAEQLPHF LLEPEDAYIV
     KNKPVELHCR AFPATQIYFK CNGEWVSQKG HVTQESLDEA TGLRIREVQI EVSRQQVEEL
     FGLEDYWCQC VAWSSSGTTK SRRAYIRIAY LRKNFDQEPL AKEVPLDHEV LLQCRPPEGV
     PVAEVEWLKN EDVIDPAQDT NFLLTIDHNL IIRQARLSDT ANYTCVAKNI VAKRRSTTAT
     VIVYVNGGWS SWAEWSPCSN RCGRGWQKRT RTCTNPAPLN GGAFCEGQAC QKTACTTVCP
     VDGAWTEWSK WSACSTECAH WRSRECMAPP PQNGGRDCSG TLLDSKNCTD GLCVLNQRTL
     NDPKSRPLEP SGDVALYAGL VVAVFVVLAV LMAVGVIVYR RNCRDFDTDI TDSSAALTGG
     FHPVNFKTAR PSNPQLLHPS APPDLTASAG IYRGPVYALQ DSADKIPMTN SPLLDPLPSL
     KIKVYDSSTI GSGAGLADGA DLLGVLPPGT YPGDFSRDTH FLHLRSASLG SQHLLGLPRD
     PSSSVSGTFG CLGGRLTIPG TGVSLLVPNG AIPQGKFYDL YLRINKTEST LPLSEGSQTV
     LSPSVTCGPT GLLLCRPVVL TVPHCAEVIA GDWIFQLKTQ AHQGHWEEVV TLDEETLNTP
     CYCQLEAKSC HILLDQLGTY VFTGESYSRS AVKRLQLAIF APALCTSLEY SLRVYCLEDT
     PAALKEVLEL ERTLGGYLVE EPKTLLFKDS YHNLRLSLHD IPHAHWRSKL LAKYQEIPFY
     HVWNGSQKAL HCTFTLERHS LASTEFTCKV CVRQVEGEGQ IFQLHTTLAE TPAGSLDALC
     SAPGNAATTQ LGPYAFKIPL SIRQKICNSL DAPNSRGNDW RLLAQKLSMD RYLNYFATKA
     SPTGVILDLW EARQQDDGDL NSLASALEEM GKSEMLVAMT TDGDC
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024